Departments of Anaesthesia and Adult Critical Care, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Acute Medicine and Intensive Care Medicine, North-West Deanery, Manchester, UK.
Anaesthesia. 2017 Mar;72(3):317-327. doi: 10.1111/anae.13763. Epub 2017 Jan 4.
Postoperative pulmonary complications are common, with a reported incidence of 2-40%, and are associated with adverse outcomes that include death, longer hospital stay and reduced long-term survival. Enhanced recovery is now a standard of care for patients undergoing elective major surgery. Despite the high prevalence of pulmonary complications in this population, few elements of enhanced recovery specifically address reducing these complications. In 2013, a prevalence audit confirmed a postoperative pulmonary complication rate of 16/83 (19.3%) in patients undergoing elective major surgery who were admitted to critical care postoperatively. A quality improvement team developed and implemented ERAS+, an innovative model of peri-operative care combining elements of enhanced recovery with specific measures aimed at reducing pulmonary complications. ERAS+ was introduced in June 2014, with full implementation in September 2014. Patients were screened during full ERAS+ implementation and again one year following implementation. Following ERAS+ implementation, postoperative pulmonary complications reduced to 24/228 (10.5%). Sustained improvement was evident one year after implementation, with a pulmonary complication rate of 16/183 (8.7%). Median (IQR [range]) length of hospital stay one year after implementation of ERAS+ also improved from 12 (9-15 [4-101]) to 9 (5.5-10.5 [3-81]) days. The ERAS+ pathway is applicable to patients undergoing elective major surgery and appears effective in reducing postoperative pulmonary complications.
术后肺部并发症较为常见,其发生率为 2-40%,与不良结局相关,包括死亡、住院时间延长和降低长期生存率。加速康复已成为择期大手术患者的常规治疗标准。尽管该人群中肺部并发症的发生率较高,但增强恢复方案中很少有针对减少这些并发症的内容。2013 年,一项流行率审计证实,在术后转入重症监护病房的择期大手术患者中,有 16/83(19.3%)例发生术后肺部并发症。一个质量改进小组制定并实施了 ERAS+,这是一种创新的围手术期护理模式,将增强恢复方案的内容与专门针对减少肺部并发症的措施相结合。ERAS+于 2014 年 6 月推出,2014 年 9 月全面实施。在全面实施 ERAS+期间对患者进行筛查,并在实施一年后再次筛查。在实施 ERAS+后,术后肺部并发症降至 24/228(10.5%)。实施一年后,肺部并发症的发生率仍保持在 16/183(8.7%),且持续改善。实施 ERAS+一年后,住院时间中位数(IQR[范围])从 12(9-15[4-101])天改善至 9(5.5-10.5[3-81])天。ERAS+方案适用于择期大手术患者,且似乎能有效降低术后肺部并发症的发生率。